Anthem Biosciences (ANTHEM) Share Price Falls 2.34% in Today’s Trade
- October 1, 2026
- Posted by: Kunal Singla
- Category: News
Anthem Biosciences Share Price is trading lower today, with Anthem Biosciences Share Price at Rs 837.25 after a 2.34% decline. The stock is valued at a market capitalisation of Rs 49,097.38 crore, placing Anthem Biosciences in the Large Cap category. Univest figures confirm the price action, but they do not point to a specific company trigger. That makes Anthem Biosciences Share Price relevant for investors tracking a share price fall in the healthcare space, especially because the move comes with detailed valuation and profitability ratios still available for review. Anthem Biosciences Stock News therefore centres on price action, fundamentals and peer context rather than any stated trigger.
For readers following Anthem Biosciences Share Price Today, the move is important because the stock remains a significant healthcare name with a premium valuation profile. The latest Univest figures show that the decline is not just a short intraday dip; it also invites a closer look at how Anthem Biosciences Share Price compares with the broader Pharmaceuticals & Drugs set.
Anthem Biosciences (ANTHEM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 837.25 |
| Previous Close | Rs 857.3 |
| Today's Move | -Rs 20.05 (-2.34%) |
| Open | Rs 850.05 |
| High | Rs 860 |
| Low | Rs 835.8 |
| Market Capitalisation | Rs 49,097.38 crore |
| Market Cap Category | Large Cap |
Anthem Biosciences Share Price opened at Rs 850.05, touched a high of Rs 860 and a low of Rs 835.80, and was last traded at Rs 837.25. The previous close stood at Rs 857.30, so the stock was down Rs 20.05, or 2.34%, at the time of observation. With a market capitalisation of Rs 49,097.38 crore, Anthem Biosciences continues to fit the Large Cap label used in Univest coverage.
The day’s range shows that Anthem Biosciences Share Price spent most of the move below the opening level and near the lower end of the range. That is the clearest price action reading from the session so far. For Anthem Biosciences Share Price Today, the key fact is simple: the stock is trading below the previous close and below the opening price, while the day high remains relatively close to the open. This makes Anthem Biosciences Share Price a notable item in today’s market updates and a stock many investors will continue to monitor as the session progresses.
Anthem Biosciences (ANTHEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 49,097.38 crore |
| P/E Ratio | 83.88x |
| P/B Ratio | 15.44x |
| ROE | 21.98% |
| ROCE | 29.62% |
| EPS | Rs 10.22 |
| Book Value Per Share | Rs 55.53 |
| Dividend Yield | 0.23% |
Anthem Biosciences (ANTHEM) fundamental metrics show P/E 83.88x, P/B 15.44x, ROE 21.98%, ROCE 29.62%. Taken on their own, these numbers offer context rather than a trading signal.
Anthem Biosciences has a market capitalisation of Rs 49,097.38 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 83.88x, P/B at 15.44x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 21.98% and ROCE of 29.62%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 10.22, book value per share of Rs 55.53, dividend yield of 0.23%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.02x, median ROE of 11.7%, median ROCE of 13.61%. They set out the fundamental picture and are not a rating on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 83.88x |
| Benchmark Median P/E | 32.02x |
| Benchmark Average P/E | 49.17x |
| Benchmark P/E Range | 3.4x to 688.17x |
| Company P/B Ratio | 15.44x |
| Benchmark Median P/B | 2.94x |
| Benchmark Average P/B | 4.37x |
| Company ROE | 21.98% |
| Benchmark Median ROE | 11.7% |
| Benchmark Average ROE | 10.68% |
| Company ROCE | 29.62% |
| Benchmark Median ROCE | 13.61% |
| Benchmark Average ROCE | 13.4% |
| Company Market Capitalisation | Rs 49,097.38 crore |
| Benchmark Median Market Cap | Rs 770.9 crore |
| Benchmark Average Market Cap | Rs 14,358.25 crore |
Anthem Biosciences (ANTHEM) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Anthem Biosciences (ANTHEM) has a P/E ratio of 83.88x, which is above the benchmark median of 32.02x, a difference of +161.96%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Anthem Biosciences (ANTHEM) has a ROE of 21.98%, which is above the benchmark median of 11.7%, a difference of +87.86%. Anthem Biosciences (ANTHEM) has a ROCE of 29.62%, which is above the benchmark median of 13.61%, a difference of +117.63%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,46,276.3 | 36.1 | 5.05 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,51,531.48 | 84.24 | 13.95 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,86,956.51 | 83.74 | 20.35 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,19,221.66 | 25.71 | 4.3 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,11,728.51 | 32.36 | 3.1 | 11.83 | 16 |
Anthem Biosciences (ANTHEM) has a P/E ratio of 83.88x compared with the displayed peer median of 36.1x. The comparison is relative and should not be read as a recommendation. Its ROE of 21.98% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 29.62% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Anthem Biosciences (ANTHEM) has a market capitalisation of Rs 49,097.38 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Anthem Biosciences
- Anthem Biosciences Share Price is down 2.34% today, so the move is visible in live market tracking.
- Anthem Biosciences Share Price remains a Large Cap name with a market capitalisation of Rs 49,097.38 crore.
- ROE of 21.98% and ROCE of 29.62% keep Anthem Biosciences Share Price relevant in Fundamental Analysis.
- P/E of 83.88 and P/B of 15.44 place Anthem Biosciences Share Price at a premium to the industry benchmark.
- Healthcare sector and Pharmaceuticals & Drugs peer comparison provide the main context for Anthem Biosciences Share Price Today.
About Anthem Biosciences
Anthem Biosciences operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Anthem Biosciences Share Price reflects a company positioned within a specialised healthcare universe where profitability ratios and valuation multiples matter greatly to investors. The stock is tracked on NSE and BSE, and its market capitalisation places it among larger listed healthcare names. Anthem Biosciences Stock News today is therefore not only about a price move, but also about how the business is being valued relative to its sector and peers.
For readers studying Anthem Biosciences Share Price as part of broader Stock Performance analysis, the company’s financial ratios and industry position provide the main lens. Univest data keeps the focus on verified price action, valuation and sector context rather than narrative guesswork.
Track Anthem Biosciences Share Price on Univest
Use Anthem Biosciences (ANTHEM) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Readers can track Anthem Biosciences Share Price on Univest for live share price updates, fundamental ratios, 52-week levels and market insights in one place. Anthem Biosciences Share Price Today, Anthem Biosciences Latest News and related stock analysis pages help users follow the company through each market update. Univest also keeps the focus on verified ratios, price movement and comparison context so that Anthem Biosciences Share Price remains easy to monitor across the trading day.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Anthem Biosciences Share Price falling today?
Ans. Anthem Biosciences Share Price is down 2.34% today and last traded at Rs 837.25. Univest figures confirm the price action, but they do not point to a specific company trigger. The previous close was Rs 857.3.
What is Anthem Biosciences Share Price today?
Ans. Anthem Biosciences Share Price was last traded at Rs 837.25. The stock was down Rs 20.05 from the previous close of Rs 857.30, making it one of today’s clear price movers in healthcare.
What is Anthem Biosciences market capitalisation?
Ans. Anthem Biosciences has a market capitalisation of Rs 49,097.38 crore. That places Anthem Biosciences Share Price in the Large Cap category and makes it one of the more significant healthcare names in today’s market discussion.
How did Anthem Biosciences trade during the day?
Ans. Anthem Biosciences opened at Rs 850.05, touched a high of Rs 860 and a low of Rs 835.80. Anthem Biosciences Share Price was last traded at Rs 837.25, which is below the opening level.
What is the valuation of Anthem Biosciences Share Price?
Ans. Anthem Biosciences Share Price carries a P/E ratio of 83.88 and a P/B ratio of 15.44. Both are above the industry benchmark, which shows the market is valuing the company at a premium.
How strong are Anthem Biosciences profitability ratios?
Ans. Anthem Biosciences reports ROE of 21.98% and ROCE of 29.62%. Those figures are above the same-industry median, which adds context to Anthem Biosciences Share Price even after today’s decline. The relevant peer median ROE is 11.7%.
What does EPS tell investors about Anthem Biosciences?
Ans. Anthem Biosciences EPS is Rs 10.22. EPS shows earnings attributable to each share, so it helps investors judge how the company’s profit generation supports Anthem Biosciences Share Price and its valuation.
How does Anthem Biosciences compare with healthcare peers?
Ans. Anthem Biosciences Share Price compares with peers such as Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla. Its ROCE is stronger than each of those names in the comparison set.
